Intestinal microbes may speed progression from HIV to AIDS

March 16, 2016 by Jim Dryden
A picture taken through an electron microscope shows the HIV virus in an immune cell. Two new studies led by researchers at Washington University School of Medicine in St. Louis point to intestinal bacteria and viruses as possible sources of inflammation and disease in those with HIV infections. Credit: C. Goldsmith

The advent of antiretroviral therapy—a combination of medications used to slow the progression of HIV—has allowed many people infected with the virus to live long, productive lives. But the therapy doesn't cure them, and those who take the drugs have an elevated risk for cardiovascular disease, cancer, kidney and liver disease, and other disorders seen in HIV patients.

HIV infection also can lead to diseases affecting the intestines, with increased gastrointestinal (GI) , diarrhea and problems with . The role of in such issues is not completely understood, but now, in two studies led by researchers at Washington University School of Medicine in St. Louis, scientists have identified and viruses as possible sources of such inflammation and disease.

Identifying the source could open the door to strategies to limit damage in the GI tract and reduce inflammation and related problems that affect patients with HIV. The two studies—one in people and the other in primates—are published March 9 in the journal Cell Host & Microbe.

"People with advanced HIV have intestinal disease and significant systemic inflammation that may cause progressive defects in immunity and speed the progression from HIV infection to AIDS," said senior investigator Herbert W. "Skip" Virgin IV, MD, PhD. "We think changes in the virome and bacterial microbiome damage gut epithelial cells and allow bacteria and viruses to leak into surrounding tissues and blood, contributing to inflammation."

Inflammation is believed to play a role in a range of disorders, including , abnormal blood lipids, diabetes and other insulin-related abnormalities.

One of the two studies monitored infected primates, and the other followed HIV-positive people in the African country of Uganda. Both showed that changes in the viral and bacterial makeup of the GI tract were linked to severe immunodeficiency due to progression of HIV in human patients and SIV (Simian immunodeficiency virus) in primates.

The researchers studied 36 rhesus monkeys, some of which were infected with SIV. They also followed 82 HIV-infected people in Uganda, 40 of whom took antiretroviral therapy and 42 of whom did not.

In the people and primates, AIDS and resulting immunodeficiency were linked to a greater number of viruses in the gut, compared with the number of gut viruses in people and primates who had a normal immune response. Those with severely weakened immune systems also had more bacterial pathogens in the gut. In the study of SIV in monkeys, the researchers found that vaccination against SIV prevented the development of those abnormalities.

The severity of immunodeficiency is determined in humans by measuring counts of immune cells called CD4 cells. A count of 200 or lower means that person's immune system is deficient. Significantly, HIV infection alone, in the absence of immunodeficiency, had a minimal effect on the number of viral and bacterial pathogens in the gut.

Virgin, the Edward Mallinckrodt Professor and head of the Department of Pathology and Immunology, said controlling the proliferation of damaging viruses and bacteria in the gut might reduce damage in the GI tract and, as a result, limit problems that affect patients with chronic HIV infection.

"In these studies, we've learned more about which viruses emerge and when they emerge following infection with SIV and HIV," said Scott Handley, PhD, assistant professor of pathology and immunology and the first author on the study focused on infections in primates. "We've also identified potentially disease-causing bacteria in the gut that appear only in severely immunocompromised people and animals."

Specifically, the researchers found AIDS and resulting immunodeficiency are associated with the expansion of adenoviruses and enterobacteriacae. Both are enteropathogens, meaning they have the potential to cause disease.

"It eventually may be possible, perhaps by treating patients with a specialized mixture of probiotics, to help restore gut health and prevent the damage to cells in the that contributes to inflammation and to an HIV infection becoming AIDS," said co-investigator Guoyan Zhao, PhD, an assistant professor of pathology and immunology.

"There are multiple, novel viruses in the intestinal ecosystems of those with SIV and HIV infection," Virgin added. "Some of those viruses, particularly the adenoviruses that can damage intestinal cells, also may have the capacity to act as vectors for vaccine delivery. Some of our collaborators are investigating that strategy and are working to develop a vaccine."

Explore further: A potential role for fat tissue as an HIV reservoir and source of chronic inflammation

More information: Monaco CL, et al. Altered virome and bacterial microbiome in human immunodeficiency virus-associated acquired immunodeficiency syndrome. Cell Host & Microbe, published online March 9, 2016.

Handley SA, et al. SIV infection-mediated changes in gastrointestinal bacterial microbiome and virome are associated with immunodeficiency and prevented by vaccination. Cell Host & Microbe, published online March 9, 2016.

Related Stories

Could probiotics help HIV patients?

January 16, 2013

Antiretroviral (ARV) drugs are the first line therapy for patients with HIV; however, ARV-treated, HIV-infected individuals still have a higher mortality rate than uninfected individuals. During the course of infection, HIV ...

Recommended for you

Success in the 3-D bioprinting of cartilage

April 28, 2017

A team of researchers at Sahlgrenska Academy has managed to generate cartilage tissue by printing stem cells using a 3-D-bioprinter. The fact that the stem cells survived being printed in this manner is a success in itself. ...

Mouse teeth providing new insights into tissue regeneration

April 27, 2017

Researchers hope to one day use stem cells to heal burns, patch damaged heart tissue, even grow kidneys and other transplantable organs from scratch. This dream edges closer to reality every year, but one of the enduring ...

Dentistry research ID's novel marker for left-handedness

April 27, 2017

Individuals with a slender lower face are about 25 percent more likely to be left-handed. This unexpected finding was identified in 13,536 individuals who participated in three national surveys conducted in the United States.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.